• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨泌乳素血症:高泌乳素血症的一个新病因。

Macroprolactinemia: a new cause of hyperprolactinemia.

作者信息

Hattori Naoki

机构信息

Department of Pharmacology, Kansai Medical University, Osaka 570-8506, Japan.

出版信息

J Pharmacol Sci. 2003 Jul;92(3):171-7. doi: 10.1254/jphs.92.171.

DOI:10.1254/jphs.92.171
PMID:12890882
Abstract

Hyperprolactinemia is not only seen in pregnancy but also in several pathological conditions such as prolactin (PRL) secreting pituitary adenoma (prolactinoma), intracranial tumors compressing the pituitary stalk or hypothalamus, and PRL stimulative drugs. However, some patients with hyperprolactinemia are diagnosed as having idiopathic hyperprolactinemia because the causes are unknown. They are subjected to repeated radiological examinations to find a microadenoma, to a long-term treatment with bromocriptine, and even to a surgical intervention. There is accumulating evidence that macroprolactinemia, in which most circulating PRL forms large protein complexes (more than 150 kDa), is a major cause of idiopathic hyperprolactinemia. The patients with macroprolactinemia are clinically characterized by the lack of hyperprolactinemia-related symptoms such as amenorrhea and galactorrhea. We found that anti-PRL autoantibody is a leading cause of macroprolactinemia that might be heterogeneous in nature. Most patients with anti-PRL autoantibodies were symptom-free and pregnancy was possible despite a marked hyperprolactinemia. Identification of macroprolactinemia is clinically important to prevent unnecessary examinations and treatments in patients with idiopathic hyperprolactinemia.

摘要

高催乳素血症不仅见于妊娠,还见于多种病理状况,如分泌催乳素(PRL)的垂体腺瘤(催乳素瘤)、压迫垂体柄或下丘脑的颅内肿瘤以及刺激PRL分泌的药物。然而,一些高催乳素血症患者因病因不明而被诊断为特发性高催乳素血症。他们需要反复接受影像学检查以寻找微腺瘤,接受溴隐亭长期治疗,甚至接受手术干预。越来越多的证据表明,大分子催乳素血症是特发性高催乳素血症的主要原因,在大分子催乳素血症中,大多数循环中的PRL形成大的蛋白质复合物(超过150 kDa)。大分子催乳素血症患者的临床特征是缺乏与高催乳素血症相关的症状,如闭经和溢乳。我们发现抗PRL自身抗体是大分子催乳素血症的主要原因,其性质可能是异质性的。大多数抗PRL自身抗体患者无症状,尽管催乳素血症明显,但仍有可能怀孕。识别大分子催乳素血症对于防止特发性高催乳素血症患者进行不必要的检查和治疗具有重要临床意义。

相似文献

1
Macroprolactinemia: a new cause of hyperprolactinemia.巨泌乳素血症:高泌乳素血症的一个新病因。
J Pharmacol Sci. 2003 Jul;92(3):171-7. doi: 10.1254/jphs.92.171.
2
Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody.抗催乳素自身抗体患者中抗体滴度与血清催乳素水平及其临床病程的相关性。
Eur J Endocrinol. 1994 May;130(5):438-45. doi: 10.1530/eje.0.1300438.
3
The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.巨泌乳素血症在高泌乳素血症患者鉴别诊断中的重要性。
Turk Neurosurg. 2008 Jul;18(3):223-7.
4
Macroprolactinemia: diagnostic, clinical, and pathogenic significance.巨泌乳素血症:诊断、临床及致病意义
Clin Dev Immunol. 2012;2012:167132. doi: 10.1155/2012/167132. Epub 2012 Dec 4.
5
Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia.巨泌乳素血症中泌乳素(PRL)分子上的抗泌乳素(PRL)自身抗体结合位点(表位)
J Endocrinol. 2006 Aug;190(2):287-93. doi: 10.1677/joe.1.06871.
6
Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.儿童和青少年期的巨泌乳素血症:高泌乳素血症的一个病因
Turk J Pediatr. 2006 Apr-Jun;48(2):143-7.
7
Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.巨泌乳素血症或单体高泌乳素血症患者的临床和实验室特征有很大重叠。
Minerva Endocrinol. 2007 Jun;32(2):79-86.
8
An infant case of macroprolactinemia with transient idiopathic central precocious puberty.一例伴有短暂特发性中枢性性早熟的巨泌乳素血症婴儿病例。
Endocr J. 2007 Dec;54(5):825-8. doi: 10.1507/endocrj.k07-010. Epub 2007 Sep 4.
9
[Hyperprolactinemia unrelated to prolactinoma].[与泌乳素瘤无关的高泌乳素血症]
Wiad Lek. 2014;67(2 Pt 1):101-11.
10
Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.高催乳素血症女性中的巨催乳素血症:一项10年随访研究
Neuro Endocrinol Lett. 2013;34(3):207-11.

引用本文的文献

1
The frequency of macroprolactinemia among patients with hyperprolactinemia in a central laboratory of a training and research hospital.一家培训和研究医院中心实验室中高催乳素血症患者的巨催乳素血症发生率。
North Clin Istanb. 2024 Nov 21;11(6):520-524. doi: 10.14744/nci.2023.94758. eCollection 2024.
2
Macroprolactinemia: a mini-review and update on clinical practice.巨泌乳素血症:临床实践的小型综述与更新
F S Rep. 2023 May 24;4(3):245-250. doi: 10.1016/j.xfre.2023.05.005. eCollection 2023 Sep.
3
Myo-Inositol Potentiates the Inhibitory Effect of Metformin on Prolactin Levels.
肌醇增强二甲双胍对催乳素水平的抑制作用。
Pharmacology. 2023;108(3):238-244. doi: 10.1159/000528542. Epub 2023 Feb 3.
4
Evaluation of hyperprolactinemia risk factors in infertile women referred to Yazd Infertility Center: A cross-sectional study.对转诊至亚兹德不孕不育中心的不孕女性高催乳素血症风险因素的评估:一项横断面研究。
Int J Reprod Biomed. 2022 Jan 12;19(12):1085-1090. doi: 10.18502/ijrm.v19i12.10059. eCollection 2021 Dec.
5
Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia.评估疑似巨泌乳素血症女性的自身抗体和免疫球蛋白 G 亚类。
J Clin Lab Anal. 2020 Nov;34(11):e23456. doi: 10.1002/jcla.23456. Epub 2020 Jun 29.
6
Biochemical diagnosis in prolactinomas: some caveats.催乳素瘤的生化诊断:一些注意事项。
Pituitary. 2020 Feb;23(1):9-15. doi: 10.1007/s11102-019-01024-z.
7
PCOS and Hyperprolactinemia: what do we know in 2019?多囊卵巢综合征与高催乳素血症:2019年我们了解了什么?
Clin Med Insights Reprod Health. 2019 Sep 9;13:1179558119871921. doi: 10.1177/1179558119871921. eCollection 2019.
8
Hyperprolactinaemia - a problem in patients from the reproductive period to the menopause.高催乳素血症——育龄期至绝经后女性患者面临的一个问题。
Prz Menopauzalny. 2017 Mar;16(1):1-7. doi: 10.5114/pm.2017.67364. Epub 2017 Apr 26.
9
Urine oligosaccharide pattern in patients with hyperprolactinaemia.高催乳素血症患者的尿寡糖模式
Glycoconj J. 2015 Nov;32(8):635-41. doi: 10.1007/s10719-015-9610-x. Epub 2015 Aug 15.
10
Bromocriptine enhances the uptake of (99m)Tc-MIBI in patients with hepatocellular carcinoma.溴隐亭可增强肝细胞癌患者对(99m)Tc-MIBI的摄取。
J Biomed Res. 2012 May;26(3):165-9. doi: 10.7555/JBR.26.20110075. Epub 2012 Apr 12.